Evolutionary or revolutionary? The transformative role of glucagon-like peptide-1 agonists in type-2 diabetes management Bockwoldt, Denise Bockwoldt, Denise Less Journal of the American Association of Nurse Practitioners. 30:S1, October 2018. Favorite PDF Permissions Free
Once-weekly glucagon-like peptide-1 receptor agonists: An overview Magwire, Melissa Magwire, Melissa Less Journal of the American Association of Nurse Practitioners. 30:S2-S3, October 2018. Favorite PDF Permissions Free
Overview of the burden of illness and the role of once-weekly glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes Hinnen, Deborah Hinnen, Deborah Less Journal of the American Association of Nurse Practitioners. 30:S4-S11, October 2018. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Free
The mode and mechanism of action of once-weekly glucagon-like peptide-1 receptor agonists in type 2 diabetes Ridge, Terry Ridge, Terry Less Journal of the American Association of Nurse Practitioners. 30:S12-S18, October 2018. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Free
Are there differences in the efficacy of once-weekly GLP-1RAs in patients with type 2 diabetes? Strong, Jodi Strong, Jodi Less Journal of the American Association of Nurse Practitioners. 30:S19-S28, October 2018. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Free
Safety of once-weekly glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes Patel, Dhiren Patel, Dhiren Less Journal of the American Association of Nurse Practitioners. 30:S29-S42, October 2018. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Free
Cardiovascular outcome trials in type 2 diabetes: A nurse practitioner perspective Kruger, Davida F. Kruger, Davida F. Less Journal of the American Association of Nurse Practitioners. 30:S43-S52, October 2018. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Free
